Sort by
Keyphrases
Encephalitis
100%
AMPA Receptor (AMPAR)
100%
Metastatic Breast Cancer
100%
Palbociclib
100%
Amino
42%
Methyl
42%
Immune Checkpoint Inhibitors
42%
Neurologic Symptoms
28%
Paraneoplastic Syndrome
28%
Older Women
14%
Immune Response
14%
Encephalopathy
14%
PET Scan
14%
Metastasis
14%
Ataxia
14%
Remission
14%
Immunosuppressive Medication
14%
Immunomodulatory
14%
Intravenous Immunoglobulin (IVIg)
14%
New Onset
14%
Rituximab
14%
Tumor Proliferation
14%
Metastatic Recurrence
14%
New Lesion
14%
Autoimmune Encephalitis
14%
Cyclin-dependent Kinase 4/6 Inhibitors
14%
Vertical Nystagmus
14%
Pharmacology, Toxicology and Pharmaceutical Science
Encephalitis
100%
AMPA Receptor
100%
Metastatic Breast Cancer
100%
Palbociclib
100%
Receptor
42%
Immune Checkpoint Inhibitor
42%
Malignant Neoplasm
28%
Neurologic Disease
28%
Paraneoplastic Syndrome
28%
Brain Disease
14%
Recurrent Disease
14%
Tumor Growth
14%
Immunotherapy
14%
Ataxia
14%
Remission
14%
Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid
14%
Rituximab
14%
Cyclin Dependent Kinase 4
14%
Polyethylene Terephthalate
14%
Allergic Encephalitis
14%
Medicine and Dentistry
Encephalitis
100%
AMPA Receptor
100%
Metastatic Breast Cancer
100%
Palbociclib
100%
Receptor
42%
Immune Checkpoint Inhibitor
42%
Malignant Neoplasm
28%
Neurologic Disease
28%
Paraneoplastic Syndrome
28%
Recurrent Disease
14%
Tumor Progression
14%
Metastatic Carcinoma
14%
Positron Emission Tomography
14%
Immunotherapy
14%
AMPA
14%
Brain Disease
14%
Ataxia
14%
Rituximab
14%
Cyclin-Dependent Kinase 4
14%
Allergic Encephalitis
14%